Zimbabwe has declined a significant US healthcare agreement worth 367 million US dollars (272 million pounds) over five years over the United States' request for confidential information.
This rejection became public following a internal memorandum dated December was leaked, which showed Head of State Emmerson Mnangagwa believed the deal was "skewed".
A government spokesperson later stated that the US was demanding access to genetic material for scientific study and commercial purposes while was not willing to share the benefits from future treatments.
"We are forced to start the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had furnished more than $1.9bn in health funding to Zimbabwe during the past two decades.
A medical body in Zimbabwe has urged more dialogue to reach a agreement suitable to all parties so the nation's vital HIV programme can continue.
Wider Background
This development follows a comparable situation in Kenya, where a high court blocked a similar deal with the US after legal challenges were filed about the safety of Kenyans' health data.
Since returning to office recently, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
USAID had overseen aid for the American government, but Trump claimed its expenditure was "inefficient" and his government was pursuing direct bilateral agreements to enhance transparency and accountability.
Based on reports, 16 African countries have to date agreed to similar agreements, constituting more than $18.3bn of fresh investment.
Details of the Declined Agreement
The funds for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this cooperation could have provided immense advantages for Zimbabwean communities, especially the 1.2 million currently on antiretroviral therapy through US-supported programmes," Tremont added.
However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to surrender its biological resources and data over an extended period, without any corresponding assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.
"In essence, our country would supply the raw materials for medical research with no certainty that the end products would be available to our population if a future health crisis arise."
National Interest and Global Health
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were upending systems previously established via the global health agency.
Mangwana cited its Pandemic Benefit-Sharing system created to deal with potential global health emergencies.
"This mechanism is designed to guarantee that when a nation contributes its data, the benefits – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the capability to develop them."
Zimbabwe's reservations over the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We are open to further discussions with our US partners on how subsequent co-operation could be structured in a way that honours the sovereignty and dignity of both nations."
Health Experts Response
Medical experts stated it recognised the official position, but suggested that negotiations should continue given that a large portion of the nation's HIV programmes depended on foreign aid.
"Where specific concerns exist, including those relating to data governance or implementation frameworks, these can often be addressed via detailed discussion and mutually agreed protections," it commented.
The halted deal highlights the continuing debate between receiving much-needed international aid and safeguarding a country's data in an ever more data-driven world.